Cargando…
Integrating heterogeneous data to facilitate COVID-19 drug repurposing
In the COVID-19 pandemic, drug repositioning has presented itself as an alternative to the time-consuming process of generating new drugs. This review describes a drug repurposing process that is based on a new data-driven approach: we put forward five information paths that associate COVID-19-relat...
Autores principales: | Prieto Santamaría, Lucía, Díaz Uzquiano, Marina, Ugarte Carro, Esther, Ortiz-Roldán, Nieves, Pérez Gallardo, Yuliana, Rodríguez-González, Alejandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520166/ https://www.ncbi.nlm.nih.gov/pubmed/34666181 http://dx.doi.org/10.1016/j.drudis.2021.10.002 |
Ejemplares similares
-
Efficacy of repurposed antiviral drugs: Lessons from COVID-19
por: Martinez, Miguel Angel
Publicado: (2022) -
Repurposing drugs as COVID-19 therapies: A toxicity evaluation
por: Ngan, Deborah K., et al.
Publicado: (2022) -
Drug repurposing against SARS-CoV-2 using computational approaches
por: Kumar, Sumit, et al.
Publicado: (2022) -
The current status of COVID-19 vaccines. A scoping review
por: Rueda-Fernández, Manuel, et al.
Publicado: (2022) -
Diabetes, inflammation, and the adiponectin paradox: Therapeutic targets in SARS-CoV-2
por: Ho, Gilbert, et al.
Publicado: (2021)